Bortezomib-induced peripheral neuropathy: Facts and genes - Authors' reply

2011-02-01

The Lancet Oncology , Volume 12 - Issue 2 p. 121

Additional Metadata
Keywords	bortezomib, cancer chemotherapy, drug withdrawal, genetic screening, human, letter, onset age, peripheral neuropathy, priority journal, quality of life, risk factor, treatment response, vincristine
Persistent URL	doi.org/10.1016/S1470-2045(11)70021-3, hdl.handle.net/1765/23589
Journal	The Lancet Oncology
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Broyl, A., Jongen, J., & Sonneveld, P. (2011). Bortezomib-induced peripheral neuropathy: Facts and genes - Authors' reply. The Lancet Oncology, 12(2). doi:10.1016/S1470-2045(11)70021-3

Publication